Daily Actions
Daily Actions
MARKET CONTEXT: SPY $771.35 (RSI 55.9, +1.27% week, +0.69% 30D, +17.22% 1Y, +7.4% vs its 200-day) | QQQ $744.50 (RSI 64.7, +3.19% week, +4.66% 30D, +25.44% 1Y, +11.9% vs its 200-day) | VIXY $16.61 (RSI 37.6, -6.84% 30D — no hedging bid even into the sharpest rate move of the stretch) | GLD $393.41 (RSI 45.2, -6.62% 30D, -5.5% vs its 200-day — stabilized rather than deepening a third time)
Price truth: every price, momentum, trend and long-horizon figure below was read directly from the 2026-09-25-dated research/market-engine/data/summaries/*.json files this session — all 154 summary files were consolidated into one 1,125-symbol index and every entry-zone, price-alert and sector-rotation figure below was validated against that index (zero cross-file mismatches on price or date for any ticker; every row carries latestDate: 2026-09-25). Sourced through all 34 of today's scans (the manifest lists 33; wfe-test-metrology is a 34th standing scan on disk this session) and all 11 candidate roundups. The tracked company-profile library (research/company-profiles/MANIFEST.md, 53 names, last refreshed 2026-09-23, two sessions old) was checked for overlap with tonight's oversold board — AA, CF, INTU, LOW and BRBR all carry an active profile — and cited for thesis only, no numbers taken from it. Regime transitions are the code-diffed transitions feed for 2026-09-25 against 2026-09-24, read directly via deno task market -- regimes:feed --json. Exit Alerts reads real holdings via the holdings CLI (holdings list / holdings positions <account>) for rh-trade (1 open position) and yawnxyz-rh (26 open positions) — the one table in this run permitted to do so; theo-active carries zero open positions. No ticker in this digest came back uncovered by the summaries — there is no missing-data request to file tonight. Prior digest for carry-forward: research/issues/2026-09-23-actions-daily-digest.md (a two-day gap).
Summary
A bond rout that has now run three cycles hit a fresh multi-decade extreme this week — the 30-year Treasury yield closed at its highest level since 2004 and the 30-year fixed mortgage rate spiked to 7.45%, the highest since April 2024 (CNBC, Bloomberg, September 24) — and it sorted the board unevenly rather than uniformly. Utilities and real estate fell into capitulation together for the first time this stretch (both RSI 24.1), while financials and regional banks did the opposite of the rate-sensitivity script: XLF's cushion widened and KRE reclaimed its 200-day outright. Growth and technology simply kept extending (XLK RSI 65.4, +19.9% above its 200-day) without needing a new catalyst. High-multiple growth names took the other side of the same rate move: cybersecurity's two-week, eleven-for-eleven green run broke hard (Zscaler's RSI fell 16.9 points, the steepest drop on that board), and the cloud/software funds gave back their two-week rally the same way — both read as a pullback inside an intact trend, not a break, since none crossed their 200-day.
Underneath that macro story, today's oversold sweep is unusually broad and unusually rich in named causes: McDonald's posted this book's first sub-25 capitulation print on a dated investor-day remodel/ad-spend announcement paired with the CEO flagging persistent high inflation and flat traffic; Novo Nordisk's break stays tied to its sourced 2030-guidance disappointment; and General Dynamics and L3Harris both fell into capitulation-tier RSI with no fresh dated program news beyond senators publicly pressing the Pentagon on F-35 parts diverted to China. Travel names (Airbnb, Expedia, Booking, Royal Caribbean) all bounced off last cycle's rout without a session-specific cause on file. The most useful cross-section tonight sits in the monster-scan "Steady Climbers" cohort — real operating companies more than 30% above their 200-day on the trailing year that dipped into the 30s on RSI this week (Aramark, James Hardie, Five Below, Monster Beverage, Helmerich & Payne, PACS Group, Grupo Aval): exactly the deep-pullback-inside-an-intact-trend shape this desk is built to find, distinct from the much larger pile of names that are simply damaged. Two boards worth flagging as forward context rather than today's entries: the wfe-test-metrology cut just posted a second 13-of-13 all-green session with every name carrying positive trailing-year alpha — the strongest book on the desk right now — and the washout-scan carries 40 "broken long-term, turning short-term" names (RMBS, PACB, IONQ, RKLB among them) that are watch-class leg-2 setups, not entries, until a base actually forms.
Entry Zones (IN ZONE NOW)
Every name below is a common-stock listing with normal trade access, sourced from today's scans, candidates and the monster-scan Steady Climbers cohort, cross-checked against the 2026-09-25 summary index. Broad index and sector funds (XLU, XLF, XLRE, KRE, HYG, LQD, TLT, IEF, BND, VIXY, VXX, GLD, SLV, ITA, PPA, TAN, LIT, KARS, RSP, IWM, VYM, SCHD, XLB, XLP, XLY, XRT, FXI, KWEB) are handled in Sector Rotation below rather than as entries. Leveraged and inverse products (TNA, SOXS) are never entry candidates on this desk and are omitted. Action tags follow the conviction-emitter vocabulary: ✅ Buy Zone / 📈 Accumulate / 🔍 Research / ⏳ Stage / ❌ Don't Buy — a beaten name with a broken trailing year never earns a checkmark, and a clinical-stage or pre-revenue biotech never earns one either, no matter how clean its chart.
EXTREME OVERSOLD (RSI < 20) — Capitulation Territory
No rows. The deepest print anywhere in today's corpus is HRL at 21.6.
OVERSOLD (RSI 20-30) — Strong Entry Zone
| Stock | Current | Zone | RSI | 30D Chg | Source | Action | Notes |
|---|---|---|---|---|---|---|---|
| HRL | $19.71 | 15.3% below its 200-day | 21.6 | -16.87% | defensive-scan | 🔍 Research | Deepening capitulation; no confirmed floor, no established cause |
| BCE | $20.97 | 12.1% below its 200-day | 22.1 | -10.73% | ai-scan | 🔍 Research | Fell into capitulation while the rest of telecom (Verizon, AT&T, SK Telecom) firmed the same week — the one holdout in a broken slide that otherwise ended |
| NEE | $76.08 | 13.1% below its 200-day | 22.8 | -9.67% | ai-scan | ⏳ Stage | Board's deepest capitulation in the ai-scan book, still the group's one positive year (+1.92%) |
| GD | $336.72 | 5.3% below its 200-day | 23.2 | -11.86% | defense-contractors, geopolitical-risk | ⏳ Stage | New capitulation entrant in the defense book alongside LHX; no fresh dated program news this window beyond senators pressing the Pentagon on F-35 parts diverted to China (Sept 24, no ticker or confirmed price effect) |
| LHX | $237.69 | 23.8% below its 200-day | 23.5 | -9.61% | defense-contractors, geopolitical-risk | 🔍 Research | Still the defense book's worst on both long-horizon measures; same lack of fresh dated program news as GD |
| CRS | $396.84 | 9.7% below its 200-day | 24.5 | -17.96% | supply-chain-traces | ⏳ Stage | Capitulation reading eased slightly (21.2→24.5) without resolving; +70.76% 1Y is the best long record in this tier |
| MCD | $236.50 | 19.0% below its 200-day | 24.7 | -11.40% | bargain-bin, defensive-scan, retail-scan | 🔍 Research | First sub-25 print this book has recorded; sourced cause on file — an investor-day remodel/ad-spend plan, CEO flagged persistent high inflation and flat traffic (retail-scan, Sept 25) |
| IMVT | $33.30 | 5.7% above its 200-day | 25.1 | -24.13% | biotech-scan | 🔍 Research | +112.5% 1Y, 5.7% above its 200-day — a deep pullback in a trend that has worked all year, but clinical-stage biotech is this desk's business-quality veto |
| BRBR | $7.91 | 49.7% below its 200-day | 25.8 | -26.69% | cultural-thesis | ❌ Don't Buy | Worst name in its book on every window; thesis flagged broken on the desk's record, still deepening |
| NKTR | $57.06 | 12.8% below its 200-day | 27.1 | -22.65% | biotech-scan | ⏳ Stage | Barely positive year sitting below its 200-day — under test, no established cause for the weakness |
| CASY | $598.46 | 18.1% below its 200-day | 27.5 | -25.85% | retail candidate, retail-scan | ⏳ Stage | Climbed out of capitulation but the month deepened again |
| PEP | $128.63 | 13.0% below its 200-day | 28.9 | -9.54% | bargain-bin | 🔍 Research | Re-entered the bargain-bin screen one edition after graduating out |
| RTX | $189.40 | 2.7% below its 200-day | 29.1 | -10.66% | defense-contractors, drone-defense, geopolitical-risk | ⏳ Stage | Its 200-day breach deepened from -1.2% to -2.7% — the line last cycle called this book's most decidable; no fresh dated program news |
| INTU | $275.79 | 31.6% below its 200-day | 29.6 | -20.26% | bargain-bin, cloud-saas candidate, lazarus-scan, tech-insider-buys | ❌ Don't Buy | Crossed below RSI 30 for the first time in this tracked window; thesis flagged broken on the desk's record |
| BWXT | $138.47 | 27.4% below its 200-day | 29.7 | -9.59% | defense-contractors | 🔍 Research | Deteriorating faster than the rest of the defense book; no fresh dated program news |
| NIO | $3.58 | 29.7% below its 200-day | 29.7 | -18.08% | ev-clean-energy | 🔍 Research | Below its 200-day, negative year; turned positive on the day but still deeply negative on the year |
| IONS | $44.50 | 37.5% below its 200-day | 29.8 | -29.77% | biotech-scan | 🔍 Research | Fails both long-horizon tests outright; deepest structural break in the biotech book, no cause on file |
APPROACHING OVERSOLD (RSI 30-40) — Watch Closely
This tier is unusually large today — 73 names — because a broad, bond-yield-shock-driven pullback hit rate-sensitive and capital-intensive names across nearly every book at once. Names carrying a real intact long trend (thesis rated intact, or above their 200-day with a strongly positive year) are called out with ✅/📈; clinical-stage or pre-revenue biotechs that otherwise pass that test still draw the business-quality veto and stay at 🔍.
| Stock | Current | Zone | RSI | 30D Chg | Source | Action | Notes |
|---|---|---|---|---|---|---|---|
| CMG | $31.33 | 10.3% below its 200-day | 30.1 | -16.10% | consumer-scan, retail-scan | 🔍 Research | Sliding further into oversold (35.6→30.1) rather than stabilizing |
| NVO | $38.80 | 15.5% below its 200-day | 31.0 | -17.78% | biotech-scan | 🔍 Research | Bounced modestly off Wednesday's low (27.5→31.0); sourced cause — 2030 growth-guidance disappointment, still unresolved |
| HD | $293.20 | 14.0% below its 200-day | 31.1 | -12.44% | bargain-bin, defensive-scan, retail-scan | 🔍 Research | Deteriorating in every scan of this stretch |
| RARE | $14.50 | 41.1% below its 200-day | 31.4 | -45.16% | biotech-scan | 🔍 Research | Fails both long-horizon tests outright; no cause on file for a third-plus straight scan |
| SBUX | $94.86 | 3.7% below its 200-day | 31.6 | -12.56% | consumer candidate, consumer-scan, cultural-thesis, defensive-scan, retail-scan | ⏳ Stage | Bounced off its lowest RSI print of the stretch; still the board's most damaged name on long-horizon measures |
| DPZ | $292.14 | 18.2% below its 200-day | 31.8 | -15.21% | bargain-bin, consumer-scan, cultural-thesis, lazarus-scan, retail-scan | 🔍 Research | Fell further on a news file untouched since June |
| TSN | $50.92 | 15.4% below its 200-day | 31.9 | -9.96% | defensive-scan | 🔍 Research | Below its 200-day, negative year |
| KRKNF | $3.23 | 37.8% below its 200-day | 32.0 | -22.91% | drone-defense | 🔍 Research | Below its 200-day; year nearly flat (-1.5%) despite the technical damage |
| SYK | $272.36 | 18.0% below its 200-day | 32.1 | -17.38% | healthcare-scan | 🔍 Research | Healthcare book's deepest structural break; no cause on file |
| NRIX | $23.01 | 18.1% above its 200-day | 32.1 | -13.85% | monster-scan (Steady Climbers) | 🔍 Research | +176.2% 1Y, 18.1% above its 200-day (Nurix Therapeutics) — intact trend, but clinical-stage biotech draws the same veto as IMVT |
| ENPH | $32.40 | 21.4% below its 200-day | 32.2 | -15.67% | ai-scan, ev-clean-energy | 🔍 Research | Fell further into oversold; news receipt stale since June |
| AA | $42.85 | 26.2% below its 200-day | 32.3 | -13.82% | macro-commodities | ⏳ Stage | Deeper below its 200-day, RSI sliding toward capitulation despite a strong year (+36.25%) |
| TTD | $12.60 | 45.8% below its 200-day | 33.2 | -3.30% | bargain-bin, lazarus-scan | 🔍 Research | Most broken name in this universe on every measure; no cause on file |
| BMRN | $60.26 | 3.0% above its 200-day | 33.3 | -8.15% | biotech-scan | 📈 Accumulate | +14.5% 1Y, back into oversold with a thin but intact long trend — commercial-stage, not pre-revenue |
| LOW | $189.28 | 18.8% below its 200-day | 33.5 | -10.02% | bargain-bin, defensive-scan, retail-scan | 🔍 Research | Thesis still rated intact on the desk's record against a chart that keeps deteriorating — the standing mismatch on this board |
| RCAT | $6.66 | 39.4% below its 200-day | 33.6 | -25.42% | drone-defense | 🔍 Research | No dated cause on file; negative-alpha count in the drone book held at 13 of 18 for a fourth straight scan |
| BKNG | $163.95 | 10.8% below its 200-day | 33.7 | -21.51% | bargain-bin, travel-leisure | 🔍 Research | Out of capitulation on the cohort's best day (+4.15%); still 10.8% below its 200-day and -26.49% on the year |
| AXON | $430.11 | 14.1% below its 200-day | 33.7 | -29.20% | drone-defense | 🔍 Research | 29.2% below its 200-day; negative year despite the book's real long-term names |
| XPEV | $10.12 | 35.9% below its 200-day | 33.8 | -13.58% | ev-clean-energy | 🔍 Research | Below its 200-day, negative year |
| CF | $114.67 | 2.8% above its 200-day | 34.0 | -8.77% | food-security | ✅ Buy Zone | Fell further into oversold despite reporting real, positive first-half earnings four days ago; thesis rated intact on the desk's record |
| HROW | $33.07 | 18.9% below its 200-day | 34.1 | -15.92% | healthcare-scan | 🔍 Research | Below its 200-day, negative year, deepening; no cause on file |
| UUUU | $11.35 | 34.1% below its 200-day | 34.1 | -27.71% | macro-commodities | 🔍 Research | Still collapsing on every window |
| PATH | $12.46 | 2.7% below its 200-day | 34.3 | -25.66% | ai-scan | ⏳ Stage | Crossed below its 200-day, fifth-plus straight week down |
| RCL | $242.70 | 15.5% below its 200-day | 34.6 | -16.31% | travel-leisure | 🔍 Research | Out of capitulation but still 15.5% below its 200-day; cohort's worst alpha |
| LCID | $4.07 | 48.2% below its 200-day | 34.7 | -17.78% | ev-clean-energy | 🔍 Research | Most damaged structure on the board, -82.34% 1Y; no cause on file |
| AVAL | $4.96 | 5.6% above its 200-day | 34.7 | -8.99% | monster-scan (Steady Climbers) | 📈 Accumulate | +48.95% 1Y, 5.6% above its 200-day (Grupo Aval, Colombian bank ADR) — intact |
| NKE | $35.75 | 27.8% below its 200-day | 35.0 | -7.36% | bargain-bin, consumer candidate, consumer-scan, cultural-thesis, lazarus-scan, retail-scan | 🔍 Research | Corpus's most cross-confirmed structural breakdown |
| FSLR | $177.71 | 21.5% below its 200-day | 35.1 | -13.70% | ai-scan, ev-clean-energy | 🔍 Research | Board's weakest solar name into the bond-yield-shock pressure hitting rate-sensitive, capital-intensive names |
| FMC | $9.58 | 28.1% below its 200-day | 35.2 | -13.54% | food-security | 🔍 Research | Worst reading in the food-security book on every window |
| LYB | $58.14 | 5.8% below its 200-day | 35.5 | -7.15% | chemicals | ⏳ Stage | 200-day breach widened from -2.5% to -5.8% on the chemicals cohort's worst single day today (-3.39%) |
| EXPE | $264.17 | 1.5% above its 200-day | 35.7 | -20.77% | travel-leisure | 📈 Accumulate | Reclaimed its 200-day this scan, lost two sessions ago; part of the industry-wide travel bounce with no confirmed session-specific cause |
| DECK | $78.67 | 22.8% below its 200-day | 35.8 | -12.07% | consumer-scan, retail-scan | 🔍 Research | Below its 200-day, negative year |
| KTOS | $45.62 | 34.6% below its 200-day | 35.8 | -13.81% | drone-defense | 🔍 Research | Below its 200-day, negative year; still under test |
| CGON | $67.15 | 6.2% above its 200-day | 35.8 | -14.37% | monster-scan (Steady Climbers) | 🔍 Research | +84.1% 1Y, 6.2% above its 200-day (CG Oncology) — intact trend, but clinical-stage biotech draws the same veto |
| HAL | $32.76 | 7.3% below its 200-day | 36.1 | -4.88% | geopolitical-risk | ⏳ Stage | Still below its 200-day, sliding further despite a strong year (+32.85%) |
| ABT | $101.29 | 3.2% below its 200-day | 36.1 | -11.23% | healthcare-scan | 🔍 Research | New oversold entrant; fails both long-horizon tests (below its 200-day, negative year); no cause on file |
| HP | $38.57 | 6.7% above its 200-day | 36.4 | -6.84% | monster-scan (Steady Climbers) | 📈 Accumulate | +76.0% 1Y, 6.7% above its 200-day (Helmerich & Payne) — intact |
| CCL | $22.25 | 19.2% below its 200-day | 36.5 | -13.05% | travel-leisure | 🔍 Research | Still 19.2% below its 200-day, death cross confirmed; earnings scheduled September 29 |
| ADBE | $235.47 | 10.4% below its 200-day | 36.6 | -13.90% | ai-scan, bargain-bin, lazarus-scan, tech-insider-buys | 🔍 Research | Thesis flagged broken (tech-insider-buys); still under test |
| TMUS | $165.43 | 13.9% below its 200-day | 36.6 | -7.89% | ai-scan | 🔍 Research | Confirmed damage, roughly unchanged |
| APD | $281.76 | 1.0% below its 200-day | 36.6 | -8.12% | chemicals | ⏳ Stage | Just lost its 200-day this scan (+0.9% cushion to -1.0%) — the chemicals book's one clean new structural break |
| SQM | $66.89 | 12.8% below its 200-day | 36.6 | -14.55% | ev-clean-energy | ⏳ Stage | Same bond-yield-shock pressure as ALB; +50.45% 1Y still the best long record in the pullback |
| NCLH | $14.61 | 25.4% below its 200-day | 36.7 | -14.51% | travel-leisure | 🔍 Research | Still the travel cohort's worst structure on every long-horizon window despite today's bounce |
| PPC | $27.82 | 17.9% below its 200-day | 36.9 | -11.09% | defensive-scan | 🔍 Research | Deepening an already broken trend |
| TE | $3.78 | 42.1% below its 200-day | 36.9 | -16.19% | ev-clean-energy | ⏳ Stage | T1 Energy posted the ev-clean-energy book's worst decline this week; the bond-yield shock hits capital-intensive, rate-sensitive solar names hardest |
| ARMK | $54.92 | 14.5% above its 200-day | 36.9 | -7.73% | monster-scan (Steady Climbers) | 📈 Accumulate | +45.83% 1Y, 14.5% above its 200-day — intact |
| NFLX | $71.15 | 16.0% below its 200-day | 37.1 | -12.66% | bargain-bin, lazarus-scan | 🔍 Research | Essentially frozen at this RSI, still -41.11% on the year |
| LMT | $519.56 | 7.6% below its 200-day | 37.1 | -8.14% | defense-contractors, drone-defense, geopolitical-risk | ⏳ Stage | Basing below its 200-day; no fresh dated program news this window |
| ALB | $109.73 | 29.7% below its 200-day | 37.1 | -18.42% | ev-clean-energy | ⏳ Stage | Gave back last scan's first green week in a month on the same bond-yield-shock pressure |
| EOSE | $3.17 | 58.7% below its 200-day | 37.4 | -5.09% | ai-scan | 🔍 Research | Deepest structural damage in both the ai-scan and insider-scan books; deepened again with no receipt on file |
| DOW | $28.02 | 12.2% below its 200-day | 37.5 | -7.62% | chemicals | ⏳ Stage | Cohort's widest 200-day breach (-12.2%) and still deepening; no news pull ties this week's split to a specific cause |
| NOC | $510.52 | 14.9% below its 200-day | 37.6 | -7.17% | defense-contractors, drone-defense, geopolitical-risk | 🔍 Research | Below its 200-day, negative year; no fresh dated program news this window |
| BA | $198.07 | 10.4% below its 200-day | 37.8 | -6.61% | defense-contractors, geopolitical-risk | 🔍 Research | Roughly flat; no fresh dated program news this window |
| MNST | $43.11 | 2.0% above its 200-day | 37.9 | -9.83% | consumer-scan, monster-scan (Steady Climbers) | 📈 Accumulate | +33.47% 1Y, 2.0% above its 200-day — intact, just crossed into oversold on RSI |
| BG | $109.00 | 5.8% below its 200-day | 38.0 | -3.75% | food-security | ⏳ Stage | Below its 200-day despite a positive year |
| JHX | $26.10 | 9.8% above its 200-day | 38.0 | -13.43% | monster-scan (Steady Climbers) | 📈 Accumulate | +40.4% 1Y, 9.8% above its 200-day (James Hardie) — intact |
| CTVA | $78.52 | at its 200-day (0.0%) | 38.1 | -5.26% | food-security | 🔍 Research | Sitting almost exactly at its 200-day average |
| UBER | $69.62 | 7.4% below its 200-day | 38.3 | -11.30% | bargain-bin | 🔍 Research | Below its 200-day, negative year |
| FIVE | $222.60 | 4.2% above its 200-day | 38.3 | -13.50% | monster-scan (Steady Climbers) | 📈 Accumulate | +46.72% 1Y, 4.2% above its 200-day (Five Below) — intact |
| ABNB | $157.47 | 10.3% above its 200-day | 38.3 | -16.27% | travel-leisure | 📈 Accumulate | Cushion rebuilt from 5.0% to 10.3% after the prior scan's near-collapse; cleared the insider-scan "selling into a dip" flag this week as it recovered; no name-specific news pull confirms a cause for the bounce |
| PACS | $41.30 | 6.6% above its 200-day | 38.7 | -6.96% | monster-scan (Steady Climbers) | 📈 Accumulate | +225.45% 1Y, 6.6% above its 200-day — the steadiest long-term climber in today's oversold band |
| TAC | $11.53 | 11.1% below its 200-day | 38.8 | -8.78% | ai-infrastructure, ai-scan | 🔍 Research | Fell into oversold for the first time in this basket's coverage (TransAlta); news pull has failed since April |
| AGRO | $10.43 | 3.0% below its 200-day | 39.4 | -5.87% | macro-commodities | ⏳ Stage | Lost its 200-day outright; still positive on the year |
| LION | $10.85 | 3.8% below its 200-day | 39.6 | -5.82% | consumer-scan | ⏳ Stage | Crossed into oversold on a mildly positive week (Lionsgate Studios); +55.67% 1Y just under the line to its 200-day |
| ZTS | $71.05 | 28.6% below its 200-day | 39.6 | -8.35% | healthcare-scan | 🔍 Research | Still the healthcare book's worst trend at -49.66% 1Y; no cause on file |
| SOUN | $6.04 | 23.9% below its 200-day | 39.7 | -13.84% | ai-scan | 🔍 Research | Deepest year damage in the ai-scan cohort |
| VZ | $47.08 | 1.7% above its 200-day | 39.7 | -6.20% | ai-scan, defensive-scan | 📈 Accumulate | Bounced off a broken shelf as telecom's two-week unexplained slide broke this week; cushion back to +1.7% above its 200-day. Also carries an active price-alert target below |
| RUN | $8.11 | 41.2% below its 200-day | 39.8 | -11.17% | ai-scan | 🔍 Research | Deeply broken on every measure |
| COGT | $32.31 | 11.7% below its 200-day | 39.8 | -12.01% | biotech-scan | 📈 Accumulate | +143.1% 1Y — one approved commercial product, not a pre-revenue lottery ticket; digesting below its 200-day |
| TOST | $30.60 | 2.3% above its 200-day | 39.8 | -17.23% | consumer-scan | 🔍 Research | Crossed above its 200-day for the first time this stretch; no dated cause on file |
| SPGI | $403.30 | 9.0% below its 200-day | 39.9 | -7.60% | bargain-bin | 🔍 Research | Under test, below its 200-day |
| PLUG | $1.98 | 20.0% below its 200-day | 39.9 | -8.76% | ev-clean-energy | 🔍 Research | Below its 200-day, negative year; no cause on file |
| UNH | $376.59 | 6.0% above its 200-day | 39.9 | -6.09% | healthcare-scan | 📈 Accumulate | Improving, just short of exiting oversold; 6.0% above its 200-day |
Price Alerts (Waiting for Entry)
| Stock | Alert | Entry Zone | Source | Set Date | Status |
|---|---|---|---|---|---|
| VZ | Entry zone | $44-$48 | ai-scan, defensive-scan, targets refresh | 07-11 (refreshed 09-25) | 🟢 IN ZONE — $47.08, RSI 39.7, weak-down trend, -6.2% 30D, inside the $44-$48 zone; telecom's two-week unexplained slide broke this week (Verizon firmed) while Bell Canada alone fell into capitulation |
| ITA | Entry zone | $210-$220 | defense-contractors, targets refresh | 04-26 (refreshed 09-25) | 🟢 IN ZONE — $213.81, RSI 31.1, down trend, -9.55% 30D, inside the $210-$220 zone for another straight session; still the defense book's most decidable unresolved line |
| SOFI | Entry zone | $16-$17 | insider-universe, targets refresh | 05-29 (refreshed 09-25) | 🟢 IN ZONE — $16.58, RSI 41.7, strong-down trend, -12.0% 30D, inside the $16-$17 zone |
| PLTR | Profit target | $187.00 | ai-infra, targets refresh | 05-01 (refreshed 09-25) | 🟠 THROUGH TARGET — $189.67, RSI 63.7, strong-up trend, +6.86% 30D, 1.4% above the $187 profit target — a decision point on an existing position, not a fresh entry signal |
| META | Pullback entry | $600-630 | ai-scan | 07-11 | 🟠 Ran even further past the zone — $751.66, RSI 71.3, +30.46% month, +0.37% 1Y — Zuckerberg debuted a $1,299 Muse Charm AI device Sept 24 (CNBC), part of what Bloomberg called Meta's "best month since 2013" toward a $2 trillion valuation; no longer a dip-buy |
| CEG | Golden-cross flip | — | ai-scan, tech-insider-buys, energy candidate | 07-11 | 🟡 Roughly steady from last edition — RSI unchanged at 43.8, death cross still confirmed, still 9.3% below its 200-day, -19.32% 1Y |
| T | Golden-cross flip | — | defensive-scan, ai-scan | 07-11 | 🟡 Price momentum turned but the cross itself has not — death cross still confirmed even as price now sits 0.9% above its 200-day (trend flag "up"), RSI 50.3, year still -10.32% |
| GLD / URA | Watch for a golden-cross flip | — | macro-commodities, etf-universe, geopolitical-risk, market-pulse | 07-25 | 🟡 Split outcome — gold stabilized rather than deepening a third time (RSI 44.4→45.2, gap narrowed marginally to -5.5%), URA kept deteriorating (-16.8% 1Y, -15.4% vs its 200-day) |
| HUBS | Watch whether the divergence resolves | — | tech-insider-buys | 08-08 | 🔴 Reversed the prior recovery — 1Y -57.8% (was -56.0%), cushion -14.7% (was -10.4%); thesis rated intact-but-priced |
| AVGO | Watch its 200-day test resolve | — | ai-scan, nvda-ecosystem, tech-insider-buys, insider-scan | 08-22 | 🟡 Still stuck — -4.2% vs its 200-day, year +4.97%, tracked insider selling deepened to -$1.9B (was -$1.6B); sixth straight scan as the chip leg's structural laggard |
| SMCI | Watch whether the 1Y ever turns positive | — | tech-insider-buys, ai-scan | 08-28 | 🟢 Deficit narrowing further — 1Y -6.44% (was -11.8%), cushion +36.1% (was +30.6%) |
| TEAM | Watch whether the extension cools | — | tech-insider-buys, monster-scan | 08-28 | 🟡 Cooled off the extension — cushion narrowed to +67.9% (was +74.9%), RSI 57.2 (was 64.2) |
| ISRG | Thesis flag vs. chart divergence | — | insider-scan, biotech-scan, healthcare-scan | 08-28 | 🟡 Repair continuing but incomplete — RSI 65.4, cushion narrowed to -10.1% (was -12.0%), 1Y improved to -7.52% (was -11.04%) |
| ORCL | Watch the 200-day / financing test | $166.25 reclaim on above-average volume, or loss of the 50-day | ai-scan, targets refresh | 09-11 | 🔴 Price kept sliding — $137.10 (was $144.56), still -52.94% 1Y, -16.7% vs its 200-day |
| MU | Watch whether the reclaim holds into the print | $989.96 (cleared) | memory candidate | 09-18 | 🟡 Extended further ahead of the print — $1,082.28, +15.33% 30D, +590.1% 1Y; the September 30 print is five sessions away and remains the real test |
| DBA | Watch for the food leg to start | Back over its 50-day with momentum above 50 | 2026-09-18 energy vertical report | 09-18 | 🔵 $28.54, momentum 48.9, essentially flat since last cycle; review date October 14 unchanged |
Exit Alerts (Holdings)
Real holdings, read this session via holdings list --json and holdings positions <account> --json — the one table in this digest permitted to read the book. theo-active carries zero open positions. Status uses a standard -15% stop-loss check (no per-position alert level is on file for either account).
rh-trade (live account):
| Stock | Alert | Type | Entry | Current | P&L | Set Date | Status |
|---|---|---|---|---|---|---|---|
| AAPL | $253.95 | Stop-loss (-15%, standard) | $298.77 | $341.07 | +14.0% | 2026-06-23 | 🟢 OK, well above the level |
yawnxyz-rh (one-time mirror seed, not actively traded — most of the positions below crossed a standard -15% stop long ago and remain open by design, not a fresh alert):
| Stock | Alert | Type | Entry | Current | P&L | Set Date | Status |
|---|---|---|---|---|---|---|---|
| HOOD | $71.77 | Stop-loss (-15%, standard) | $84.44 | $119.40 | +41.4% | 2026-07-10 | 🟢 OK |
| SPCX | $114.75 | Stop-loss (-15%, standard) | $135.00 | $148.67 | +10.1% | 2026-07-10 | 🟢 OK |
| ASAN | $7.29 | Stop-loss (-15%, standard) | $8.58 | $9.02 | +5.1% | 2026-07-10 | 🟢 OK |
| NOK | $13.93 | Stop-loss (-15%, standard) | $16.39 | $10.39 | -36.6% | 2026-07-10 | 🚨 Below level (long-standing) |
| AS | $30.85 | Stop-loss (-15%, standard) | $36.29 | $27.77 | -23.5% | 2026-07-10 | 🚨 Below level (long-standing) |
| ABNB | $135.50 | Stop-loss (-15%, standard) | $159.41 | $157.47 | -1.2% | 2026-07-10 | 🟢 OK |
| NET | $125.76 | Stop-loss (-15%, standard) | $147.95 | $349.02 | +135.9% | 2026-07-10 | 🟢 OK |
| MRNA | $134.04 | Stop-loss (-15%, standard) | $157.69 | $198.88 | +26.1% | 2026-07-10 | 🟢 OK |
| META | $203.72 | Stop-loss (-15%, standard) | $239.67 | $751.66 | +213.6% | 2026-07-10 | 🟢 OK |
| REA | $16.15 | Stop-loss (-15%, standard) | $19.00 | $11.04 | -41.9% | 2026-07-10 | 🚨 Below level (long-standing) |
| ZM | $315.49 | Stop-loss (-15%, standard) | $371.16 | $89.71 | -75.8% | 2026-07-10 | 🚨 Below level (long-standing) |
| PHGE | — | — | $17.48 | — | — | 2026-07-10 | ⚠️ DATA HOLD — price stale/unavailable, cannot compute P&L |
| TWLO | $335.72 | Stop-loss (-15%, standard) | $394.96 | $275.80 | -30.2% | 2026-07-10 | 🚨 Below level (long-standing) |
| BNTX | $93.33 | Stop-loss (-15%, standard) | $109.80 | $98.52 | -10.3% | 2026-07-10 | ⚠️ APPROACHING |
| SOFI | $16.12 | Stop-loss (-15%, standard) | $18.97 | $16.58 | -12.6% | 2026-07-10 | ⚠️ APPROACHING |
| TWST | $165.59 | Stop-loss (-15%, standard) | $194.81 | $182.83 | -6.2% | 2026-07-10 | 🟢 OK |
| ARMP | $5.07 | Stop-loss (-15%, standard) | $5.97 | $3.74 | -37.4% | 2026-07-10 | 🚨 Below level (long-standing) |
| COIN | $285.12 | Stop-loss (-15%, standard) | $335.44 | $195.11 | -41.8% | 2026-07-10 | 🚨 Below level (long-standing) |
| PINS | $70.96 | Stop-loss (-15%, standard) | $83.48 | $18.90 | -77.3% | 2026-07-10 | 🚨 Below level (long-standing) |
| FIGS | $34.05 | Stop-loss (-15%, standard) | $40.06 | $13.42 | -66.5% | 2026-07-10 | 🚨 Below level (long-standing) |
| AMC | $59.76 | Stop-loss (-15%, standard) | $70.30 | $2.94 | -95.8% | 2026-07-10 | 🚨 Below level (long-standing) |
| NTLA | $68.31 | Stop-loss (-15%, standard) | $80.37 | $11.75 | -85.4% | 2026-07-10 | 🚨 Below level (long-standing) |
| ABCL | $41.62 | Stop-loss (-15%, standard) | $48.97 | $12.70 | -74.1% | 2026-07-10 | 🚨 Below level (long-standing) |
| DNA | $370.51 | Stop-loss (-15%, standard) | $435.89 | $10.66 | -97.6% | 2026-07-10 | 🚨 Below level (long-standing) |
| FUBO | $379.37 | Stop-loss (-15%, standard) | $446.32 | $9.64 | -97.9% | 2026-07-10 | 🚨 Below level (long-standing) |
| EDIT | $57.00 | Stop-loss (-15%, standard) | $67.06 | $2.58 | -96.2% | 2026-07-10 | 🚨 Below level (long-standing) |
The two names worth actually watching this cycle are BNTX and SOFI, both freshly inside the -10% to -15% approach band rather than long-since blown through it. Everything tagged "long-standing" below the level is old, recorded damage in a seed account that is not being actively traded — not a new signal tonight.
Sector Rotation Signals
| Signal | Trigger | What It Means | Status |
|---|---|---|---|
| The bond rout hit a fresh multi-decade extreme | 30-year Treasury yield closed at its highest level since 2004; 30-year fixed mortgage rate spiked to 7.45%, the highest since April 2024 (CNBC, Bloomberg, Sept 24) | All five bond ETFs (TLT, IEF, HYG, LQD, BND) remain deeply below their 200-day and negative on the year — none is testing a bottom | 🔴 Escalating, fresh extreme |
| Utilities and real estate fell into capitulation together for the first time this stretch | XLU RSI 24.1 (year -7.49%, 200-day gap -11.1%); XLRE RSI 24.1 but its trailing year turned positive (+0.22%) for the first time | The board's only two sub-25 prints; XLRE's positive year turn is a genuine split signal — capitulation on RSI sitting on top of a repairing long-horizon number, not confirmed damage | 🔴 Confirmed capitulation, XLRE ambiguous |
| Financials and regional banks broke from the rate-sensitivity script | XLF RSI 28.4→32.9, cushion +1.5%→+2.1%, year +1.45%→+2.56%; KRE RSI 27.2→37.7, reclaimed its 200-day outright | Stabilized/repaired instead of deteriorating further with the rest of the rate-sensitive complex | 🟢 Repair, against the pattern |
| Housing extended its divergence to a second straight week | XHB RSI 38.5→43.3, ITB RSI 40.9→43.5, both improving on trailing year even as the 30-year mortgage rate spiked | Two cycles of confirmation now, even as the mortgage-rate headline moved the wrong way | 🟢 Two-cycle confirmation |
| Growth and technology kept extending without a new catalyst | XLK RSI 65.4 (+19.9% vs its 200-day, board's best sector reading), QQQ 64.7, SMH 62.7, VUG 63.6, MTUM 62.2 | Continuing, not restarting, the multi-week advance | 🟢 Extending |
| Breadth remains genuinely unresolved | RSP RSI 34.6→36.1, IWM 34.4→34.9 (both ticked up marginally) against MarketWatch (Sept 23) reporting breadth concentration at its narrowest since the dot-com peak and CNBC (Sept 24) reporting bond liquidation "wrecking" small caps specifically | A marginal RSI uptick is not the same as a resolved concentration problem — needs a second confirming week before either read is trusted | 🟡 Unresolved |
| Cybersecurity's two-week, eleven-for-eleven green run broke hard | Zscaler RSI 70.5→53.6 (steepest drop on the board); Okta, CrowdStrike, Palo Alto and Twilio all cooled together, coinciding with the same bond-yield shock | High-multiple growth names de-rated together as yields spiked; none broke their 200-day cushions | 🟡 Cooling, not breaking |
| Cloud and software gave back their two-week rally the same way | WCLD RSI 57.5→49.8 (steepest drop of the four funds); IGV, CLOU and SKYY all fell together on the same bond-yield-shock read | All four funds remain solidly above their 200-day — a pullback inside an intact trend, not a break | 🟡 Pullback, trend intact |
| Gold stabilized rather than deepening a third time | RSI 44.4→45.2, 200-day gap narrowing marginally to -5.5% | First non-deteriorating week for gold in this stretch, even as the rate story escalated | 🟡 Stabilizing |
| No hedging bid even into the sharpest rate move of the stretch | VIXY RSI 38.7→37.6, VXX 38.5→37.2, both continuing to cool | Same positioning read flagged for several cycles, now sitting against the sharpest rate move yet | 🟡 Watch |
| Airlines round-tripped back to green across the board | All six airline names closed higher after Wednesday's red session; Delta upgraded to a confirmed strong-up trend with a golden cross; JETS reclaimed its 200-day for the first time in this series | The desk's own oil proxy fell 3.1% the same day on a Wednesday Hormuz-reopening report — a plausible tailwind for fuel costs, but no news receipt on any of the six ties today's gains to it specifically | 🟢 Confirming |
Regime Transitions
Source: the code-diffed transitions feed for 2026-09-25 against 2026-09-24 — 50 items (12 flagged inert — universe churn or thin-liquidity noise, still listed where thesis-rated).
| Stock | From | To | Thesis | Tape Date |
|---|---|---|---|---|
| PLTR | pullback | uptrend | intact | 2026-09-25 |
| SDGR | parabolic | uptrend | intact | 2026-09-25 |
| MCD | downtrend | collapse | unrated | 2026-09-25 |
| LION | pullback | collapse | unrated | 2026-09-25 |
| BMRN | uptrend | pullback | unrated | 2026-09-25 |
| NRIX | uptrend | pullback | unrated | 2026-09-25 |
| LMT | pullback | basing | unrated | 2026-09-25 |
| PACS | pullback | basing | unrated | 2026-09-25 |
| KTOS | collapse | downtrend | unrated | 2026-09-25 (inert) |
| EOSE | downtrend | collapse | unrated | 2026-09-25 (inert) |
The only two thesis-rated crossings both point up: PLTR (pullback→uptrend, intact) and SDGR (parabolic→uptrend, intact). The rest of the named cluster independently cross-confirms tonight's Entry Zones reads without depending on either: MCD's downtrend→collapse crossing matches its fresh capitulation print above; LION's pullback→collapse matches its new oversold entrant status; BMRN's and NRIX's uptrend→pullback crossings match their "deep pullback, watch the reclaim" framing; LMT's and PACS's pullback→basing crossings match their Stage/Accumulate calls; and KTOS's and EOSE's continuing-collapse crossings (both inert) match their unresolved-damage reads.
Beyond the ten rows above, the remaining 40 items sort into fourteen state-pair combinations with no single dominant theme: uptrend→pullback 12, downtrend→collapse 9, pullback→collapse 5, collapse→downtrend 3, pullback→basing 3, uptrend→basing 3, basing→downtrend 2, breakout→uptrend 2, parabolic→uptrend 2, pullback→uptrend 2, pullback→downtrend 2, parabolic→pullback 1, basing→pullback 1, pullback→breakout 1, downtrend→basing 1, collapse→pullback 1 — broad two-directional churn, not a market moving as one.
Insider Activity Summary
| Signal | Stocks | Implication |
|---|---|---|
| Golden signal (oversold + buying): zero for a ninth straight week | None — nothing in the 59-name insider universe closed below momentum 30 with active buying | The clean read now spans nine full cycles |
| Selling into a dip: cleared this week | ABNB's RSI recovered out of oversold (26.5→38.3), clearing the one flag from last edition | A sharp pullback insiders were positioned against has now fully repaired |
| Insider buying frozen a fourth straight week | TSLA +$221.0M, CRSP +$26.7M, ASAN +$4.5M (roughly halved from +$8.7M), INTC +$2.4M, TSM +$1.5M | A frozen figure is not a fresh signal; Asana's carried buying dropping by half is the one real change |
| Heaviest tracked selling, largely unchanged at the top | AMZN -$9.4B, NVDA -$4.0B, LLY -$3.0B, PLTR -$2.0B, AVGO -$1.9B (deepened from -$1.6B) | Same leaders atop the truncated top-20 report; Broadcom's selling widening while its chart sits nearly flat at its 200-day is the one notable move |
| Heavy selling stays concentrated in the strongest trends | AMD (+291.02% 1Y), Twilio (+172.18%), DDOG (+96.29%), DocuSign-adjacent DOCN (+297.81%) | Insider selling in this universe remains a poor standalone sell signal; each name's trend has to be read separately |
| Overbought extreme thinned from seven names to four | ZS 70.5→53.6 (steepest drop), CRWD 68.9→62.1, PANW 62.7→54.4, TWLO 75.4→62.5; only MRNA (76.1), AMD (73.0), TMO (72.5) and META (71.3) still read above 70 | The broadest single change this session, tied to the same bond-yield shock sorting the sector boards above |
| EOSE, NFLX and PINS remain the cleanest cases where insider selling and the chart agree | EOSE deepened again (1Y -69.78%, was -64.76%), NFLX frozen at -41.11% on the year, PINS -43.50% | Selling and the chart both broken — damage, not a value signal |
| The report prints only its top 20 sellers by size | 52 selling names counted, 32 smaller positions unnamed | A known truncation in the source report, not a data loss |
Pending Research Actions
| Action | Source | Priority | Status |
|---|---|---|---|
| Does the bond rout's fresh multi-decade extreme (30-year yield highest since 2004, mortgage 7.45%) keep escalating into a third-plus week, or does this mark a near-term peak? | market-pulse | High | Carried from 09-23, escalated |
| Does XLRE's positive year turn (+0.22%) mark a genuine repair, or a one-week statistical artifact sitting on top of a fresh capitulation print? | market-pulse | High | New |
| Does financials'/KRE's stabilization against the rate-sensitivity script hold a second cycle, or reverse if the bond rout keeps escalating? | market-pulse | High | New |
| Does the equal-weight benchmark's/small-cap RSI uptick mark real breadth repair, or does the sourced dot-com-era concentration story (MarketWatch, Sept 23) and small-cap-specific liquidation pressure (CNBC, Sept 24) reassert next cycle? | market-pulse | High | Carried, restated |
| What drove McDonald's first sub-25 capitulation print in full, and does the sourced investor-day remodel/ad-spend plan explain the size of the move, or is more coming out of the earnings-call summary? | bargain-bin, retail-scan, defensive-scan | High | New |
| Does Novo Nordisk's sourced 2030-guidance break stabilize above its nearest shelf, and does Nektar's identically-shaped but unsourced capitulation ever get an explanation? | biotech-scan | Medium | Carried |
| Does Carpenter Technology's capitulation reading (easing to 24.5 from 21.2, still unresolved) ever reclaim its 200-day? | supply-chain-traces | Medium | Carried, deepened then eased |
| Does the cybersecurity/cloud cooling (ZS, OKTA, CRWD, PANW, TWLO, WCLD, IGV) extend into a real pullback, or stabilize here? | cybersec, cloud-etfs, insider-scan, tech-insider-buys | Medium | New |
| Does housing's two-cycle divergence survive a third week now that the 30-year fixed mortgage rate has spiked to a post-April-2024 high? | market-pulse | Medium | New |
| Does Arm's structural giveback (RSI 71.1→61.2, half of its 36% run reversed) find a floor, or does the extension resume? | nvda-ecosystem | Medium | New |
| Does MU's extension hold into the September 30 print, or is the reclaim purely momentum ahead of the real test? | memory candidate, MU target | Medium | Carried |
| Does DBA's food leg resolve by the October 14 review date? | DBA target desk call | Low | Carried, unchanged |
The Gold
Top Signal
The bond rout that has run this board for three straight cycles hit a fresh multi-decade extreme — the 30-year Treasury yield closed at its highest level since 2004 and the 30-year fixed mortgage rate spiked to 7.45%, the highest since April 2024 — and for the first time this stretch it sorted the equity board unevenly rather than uniformly. Utilities and real estate both fell into capitulation together, the board's first shared sub-25 print of the run, while financials and regional banks did the exact opposite of the rate-sensitivity script: KRE reclaimed its 200-day outright and XLF's cushion widened. Growth and technology simply kept extending without needing a new catalyst, while the same rate move broke a two-week, eleven-for-eleven green run in cybersecurity and gave back a two-week rally in cloud/software — both read as a pullback inside an intact trend, not a break, since neither group's funds lost their 200-day. Tonight's oversold sweep is the broadest of this tracked stretch — 90 individual names below RSI 40, none below 20 — and it is unusually well-sourced. McDonald's first-ever sub-25 print carries a dated cause (an investor-day remodel/ad-spend plan and the CEO flagging persistent high inflation and flat traffic); Novo Nordisk's break stays tied to its known 2030-guidance disappointment; General Dynamics and L3Harris both fell into capitulation with no fresh program news beyond senators pressing the Pentagon on diverted F-35 parts; and every travel name that cracked last cycle (Airbnb, Expedia, Booking, Royal Caribbean) bounced back without a session-specific cause on file. The most useful read tonight sits in the monster-scan Steady Climbers cohort — real operating companies more than 30–225% above their trailing-year lows and still above their 200-day that simply dipped into the low 30s on RSI this week: Aramark, James Hardie, Five Below, Monster Beverage, Helmerich & Payne, PACS Group and Grupo Aval all pass both long-horizon tests cleanly. CF Industries is the one name in the broader 30-40 band with a thesis rated
intacton the desk's own record; BioMarin and Cogent Biosciences clear the bar for commercial-stage biotech accumulation. Everything else oversold tonight — the great majority of the 90 — is a rate shock and a handful of dated, company-specific misses doing the work, not a broad discount.
Key Discoveries
| Discovery | Implication |
|---|---|
| The 30-year Treasury yield closed at its highest level since 2004 and the 30-year fixed mortgage rate spiked to 7.45%, the highest since April 2024, in the same week | A third straight cycle of bond-rout escalation, not a pause or a repair |
| Utilities and real estate fell into capitulation together for the first time this stretch, while financials and regional banks stabilized against the same rate move | The rate shock sorted the board unevenly this cycle rather than uniformly hitting every rate-sensitive name |
| McDonald's posted this book's first-ever sub-25 capitulation print with a dated, sourced cause (investor-day remodel/ad-spend plan, CEO flagged persistent inflation and flat traffic) | A genuinely company-specific break, not just macro repricing |
| The monster-scan Steady Climbers cohort produced seven clean deep-pullback-inside-an-intact-trend names (Aramark, James Hardie, Five Below, Monster Beverage, Helmerich & Payne, PACS Group, Grupo Aval), all above their 200-day with 30%+ trailing-year returns | The highest-quality entry candidates tonight sit outside the standard oversold scans, in the momentum-discovery board |
| Cybersecurity's two-week, eleven-for-eleven green run and cloud/software's own two-week rally both broke the same week, on the same bond-yield shock, without any fund in either group losing its 200-day | A pullback inside an intact trend for both groups, not a break |
| The regime-transitions feed independently cross-confirmed eight of tonight's Entry Zone reads (MCD, LION, BMRN, NRIX, LMT, PACS, KTOS, EOSE) without depending on the scan corpus | Two independent measurement paths landing on the same names raises confidence in the reads, not just the coincidence |
Ninety individual names closed below RSI 40 tonight and none closed below 20 — the broadest oversold sweep of this tracked stretch, yet only CF Industries carries a thesis rated intact on the desk's own record |
Breadth of the pullback does not translate into breadth of genuine discount; most of tonight's board is damage, not opportunity |
Sourced from all 34 of today's scans (ai-infrastructure, ai-scan, airlines, bargain-bin, biotech-scan, chemicals, cloud-etfs, consumer-scan, crypto-scan, cultural-thesis, cybersec, defense-contractors, defensive-scan, drone-defense, etf-universe, ev-clean-energy, food-security, geopolitical-risk, healthcare-scan, insider-scan, lazarus-scan, macro-commodities, market-pulse, monster-discover, monster-scan, nvda-ecosystem, optical-supply-chain, retail-scan, scan-monster-etf-v2, supply-chain-traces, tech-insider-buys, travel-leisure, washout-scan, wfe-test-metrology), all 11 candidate roundups (ai-infra, biotech, cloud-saas, consumer, crypto, energy, mag7, memory, retail, space, web-cloud), the tracked company-profile manifest (53 names, dated 2026-09-23, checked for overlap only), and the code-diffed regime-transitions feed for 2026-09-25 against 2026-09-24. Every price, RSI, 30-day change, one-year change and 200-day distance figure above traces to the 2026-09-25-dated summary index built from all 154 files in research/market-engine/data/summaries/; the index was cross-checked for internal consistency (price and date agreement across every watchlist file carrying the same symbol) with zero mismatches found. No ticker referenced in this digest came back missing from that index.
Sources
- Price, momentum, trend and long-horizon truth:
research/market-engine/data/summaries/*.json(154 files, 2026-09-25 close) — consolidated into a single symbol index this session and used directly for every Entry Zone, Price Alert and Sector Rotation figure above. - Scan corpus:
research/scans/2026-09-25-*.md(34 files, listed above). - Candidate roundups:
research/candidates/2026-09-25-*.md(11 files: ai-infra, biotech, cloud-saas, consumer, crypto, energy, mag7, memory, retail, space, web-cloud). - Company profiles, overlap check only:
research/company-profiles/MANIFEST.md(53 active profiles, dated 2026-09-23). - Regime transitions:
deno task market -- regimes:feed --json, read directly this session — 2026-09-25 against 2026-09-24. - Real holdings:
deno task market -- holdings list --jsonanddeno task market -- holdings positions <account> --json, read directly this session forrh-tradeandyawnxyz-rh. - Bond-rout escalation and mortgage-rate spike: cited inline within
research/scans/2026-09-25-market-pulse.md(CNBC and Bloomberg, September 24 captures referenced there). - McDonald's investor-day cause: cited inline within
research/scans/2026-09-25-retail-scan.mdandresearch/scans/2026-09-25-bargain-bin.md. - Novo Nordisk 2030-guidance cause: cited inline within
research/scans/2026-09-25-biotech-scan.md. - F-35 parts/China Pentagon item: cited inline within
research/scans/2026-09-25-defense-contractors.mdandresearch/scans/2026-09-25-geopolitical-risk.mdfrontmatter summaries. - Meta's Muse Charm device and "best month since 2013": cited inline within
research/scans/2026-09-25-ai-scan.md. - Costco Q4 beat, Okta/Permiso-adjacent cooling, Synaptics/onsemi acquisition: cited inline within
research/scans/2026-09-25-defensive-scan.md,research/scans/2026-09-25-cybersec.mdandresearch/scans/2026-09-25-nvda-ecosystem.mdrespectively. - Prior digest for carry-forward:
research/issues/2026-09-23-actions-daily-digest.md. - Target crossings:
research/targets/2026-04-10-vz-target-entry-zone.md,research/targets/2026-04-26-ita-target-entry-zone.md,research/targets/2026-05-29-sofi-target-entry-zone.md,research/targets/2026-05-01-pltr-target-profit-target.md,research/targets/2026-09-18-dba-target-desk-call.md.
Related
2 eventsNo direct external sources are attached to this read.